|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/48 | |
| A61K 38/36 | |||
| A61K 45/06 | |||
| A61K 9/22 | |||
| A61P 3/10 |
| (11) | Patento numeris | 2437732 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10784223.9 |
| Europos patento paraiškos padavimo data | 2010-06-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-04-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-05-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/037605 |
| Data | 2010-06-07 |
| (87) | Numeris | WO 2010/141938 |
| Data | 2010-12-09 |
| (30) | Numeris | Data | Šalis |
| 217906 P | 2009-06-05 | US |
| (72) |
CINCOTTA, Anthony, H., US
|
| (73) |
VeroScience LLC,
1334 Main Road, Tiverton RI 02878,
US
|
| (54) | COMBINATION OF DOPAMINE AGONISTS PLUS FIRST PHASE INSULIN SECRETAGOUGES FOR THE TREATMENT OF METABOLIC DISORDERS |
| COMBINATION OF DOPAMINE AGONISTS PLUS FIRST PHASE INSULIN SECRETAGOUGES FOR THE TREATMENT OF METABOLIC DISORDERS |